Exact Mass: 452.2006
Exact Mass Matches: 452.2006
Found 500 metabolites which its exact mass value is equals to given mass value 452.2006
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
8-Butanoylneosolaniol
8-Butanoylneosolaniol is produced by Fusarium sporotrichioides.
8-Isobutanoylneosolaniol
8-Isobutanoylneosolaniol is produced by Fusarium sporotrichioides. Production by Fusarium sporotrichioides
2-(3-(4-((1H-Indazol-5-yl)amino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide
Fumaryl diketopiperazine
9alpha-Acetoxymelnerin B
[3aR-(3aalpha,4aalpha,5alpha,7abeta,9abeta)]-5-[(6-O-Acetyl-beta-D-glucopyranosyl)oxy]-3a,4,4a,5,6,7,7a,9a-octahydro-5,8-dimethyl-3-methylene-azuleno[6,5-b]furan-2(3H)-one
Absinthifolide
4,8,12-Tris(acetyloxy)-10-[(acetyloxy)methyl]-2,6-dimethyl-2,6,10-dodecatrienal
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] (Z)-4-acetyloxy-2-(hydroxymethyl)but-2-enoate
(7R,8R)-4-O-(glycer-2-yl)-7,9,9-trihydroxy-3,3-dimethoxy-8-O-4-neolignan
1-<4-O-(2-hydroxy-1-hydroxymethylethyl)-3-methoxyphenyl>-2-<4-(1-propanol)-3-methoxyphenyl>-propane-1,3-diol|1-[4-O-(2-hydroxy-1-hydroxymethylethyl)-3-methoxyphenyl]-2-[4-(1-propanol)-3-methoxyphenyl]-propane-1,3-diol
1,3-Di(4-hydroxybenzyl)-4-methoxy-9,10-dihydrophenanthrene-2,7-diol
Tetra-Ac-8-(1-Hydroxypropyl)-2-(2-penten-4-ynyl)-3,5,6-oxocanetrio
ochrindole A
A bisindole alkaloid that is phenol bearing a 3,3-dimethylallyl group at position 4, two methoxy groups at positions 3 and 6, and two indol-3-yl groups at positions 2 and 5. It is a natural product isolated from the sclerotia of Aspergillus orbraceus, with moderate activity against some insects, as well as Gram-positive bacteria.
(1R*,4R*,5R*,8S*,10R*)-1,4-Epoxy-1-ethoxy-5-hydroxy-8-methacryloxy-13-acetoxygermacra-5E,7(11)-dien-6,12-olide
2-(2,4-dihydroxyphenyl)-5-hydroxy-7-methoxy-3-(3-methylbut-2-en-1-yl)-6-(3-methyl-2-oxobutyl)-4H-1-benzopyran-4-one|hypargyflavone B
5,7,3,4-Tetrahydroxy-3-methoxy-8,5-diprenylflavone
2,7-((1,1-Bi(1H-indole)-3,3-diyl)bismethylene)dodecahydrocyclobutadipyrazine-3,6-dione
macaranone B
A tetrahydroxyflavone that is flavonol substituted by additional hydroxy groups at positions 5, 7 and 3, a methoxy group at position 4 and a geranyl group at position 2. It has been isolated from the twigs of Morus nigra.
Fluocinolone Acetonide
C - Cardiovascular system > C05 - Vasoprotectives > C05A - Agents for treatment of hemorrhoids and anal fissures for topical use > C05AA - Corticosteroids D - Dermatologicals > D07 - Corticosteroids, dermatological preparations > D07A - Corticosteroids, plain > D07AC - Corticosteroids, potent (group iii) D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids S - Sensory organs > S01 - Ophthalmologicals > S01B - Antiinflammatory agents > S01BA - Corticosteroids, plain C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid S - Sensory organs > S02 - Otologicals > S02B - Corticosteroids > S02BA - Corticosteroids D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8722; ORIGINAL_PRECURSOR_SCAN_NO 8717 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8755; ORIGINAL_PRECURSOR_SCAN_NO 8753 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8759; ORIGINAL_PRECURSOR_SCAN_NO 8757 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8810; ORIGINAL_PRECURSOR_SCAN_NO 8805 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8806; ORIGINAL_PRECURSOR_SCAN_NO 8804 CONFIDENCE standard compound; INTERNAL_ID 466; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8815; ORIGINAL_PRECURSOR_SCAN_NO 8813 CONFIDENCE standard compound; INTERNAL_ID 2402
C23H32O9_Cyclohexaneacetic acid, 6-[4-(acetyloxy)-3-hydroxy-2-methylene-1-oxobutoxy]-4-ethenyl-2-hydroxy-3-[1-(hydroxymethyl)ethenyl]-4-methyl-alpha-methylene-, methyl ester
C23H32O9_D-Glucitol, 1,5-anhydro-1-C-[2,6-dihydroxy-3-(methoxycarbonyl)-4-[(3Z,5Z)-3,5-nonadien-1-yl]phenyl]-, (1S)
[5-ethenyl-3-hydroxy-4-(3-hydroxyprop-1-en-2-yl)-2-(3-methoxy-3-oxoprop-1-en-2-yl)-5-methylcyclohexyl] 4-acetyloxy-3-hydroxy-2-methylidenebutanoate
methyl 2,4-dihydroxy-6-[(3Z,5Z)-nona-3,5-dienyl]-3-[(2S,3R,4R,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzoate
Ala Ala Glu Tyr
Ala Ala Tyr Glu
Ala Cys Phe Ile
Ala Cys Phe Leu
Ala Cys Ile Phe
Ala Cys Leu Phe
Ala Asp Phe Thr
Ala Asp Thr Phe
Ala Glu Ala Tyr
Ala Glu Phe Ser
Ala Glu His Pro
Ala Glu Pro His
Ala Glu Ser Phe
Ala Glu Tyr Ala
Ala Phe Cys Ile
Ala Phe Cys Leu
Ala Phe Asp Thr
Ala Phe Glu Ser
Ala Phe Ile Cys
Ala Phe Leu Cys
Ala Phe Ser Glu
Ala Phe Thr Asp
Ala His Glu Pro
Ala His Pro Glu
Ala Ile Cys Phe
Ala Ile Phe Cys
Ala Leu Cys Phe
Ala Leu Phe Cys
Ala Pro Glu His
Ala Pro His Glu
Ala Ser Glu Phe
Ala Ser Phe Glu
Ala Thr Asp Phe
Ala Thr Phe Asp
Ala Tyr Ala Glu
Ala Tyr Glu Ala
Cys Ala Phe Ile
Cys Ala Phe Leu
Cys Ala Ile Phe
Cys Ala Leu Phe
Cys Phe Ala Ile
Cys Phe Ala Leu
Cys Phe Ile Ala
Cys Phe Leu Ala
Cys His Pro Pro
Cys Ile Ala Phe
Cys Ile Phe Ala
Cys Leu Ala Phe
Cys Leu Phe Ala
Cys Pro His Pro
Cys Pro Pro His
Asp Ala Phe Thr
Asp Ala Thr Phe
Asp Phe Ala Thr
Asp Phe Thr Ala
Asp Gly Val Tyr
Asp Gly Tyr Val
Asp Thr Ala Phe
Asp Thr Phe Ala
Asp Val Gly Tyr
Asp Val Tyr Gly
Asp Tyr Gly Val
Asp Tyr Val Gly
Glu Ala Ala Tyr
Glu Ala Phe Ser
Glu Ala His Pro
Glu Ala Pro His
Glu Ala Ser Phe
Glu Ala Tyr Ala
Glu Phe Ala Ser
Glu Phe Gly Thr
Glu Phe Ser Ala
Glu Phe Thr Gly
Glu Gly Phe Thr
Glu Gly Thr Phe
Glu His Ala Pro
Glu His Pro Ala
Glu Pro Ala His
Glu Pro His Ala
Glu Ser Ala Phe
Glu Ser Phe Ala
Glu Thr Phe Gly
Glu Thr Gly Phe
Glu Tyr Ala Ala
Phe Ala Cys Ile
Phe Ala Cys Leu
Phe Ala Asp Thr
Phe Ala Glu Ser
Phe Ala Ile Cys
Phe Ala Leu Cys
Phe Ala Ser Glu
Phe Ala Thr Asp
Phe Cys Ala Ile
Phe Cys Ala Leu
Phe Cys Ile Ala
Phe Cys Leu Ala
Phe Asp Ala Thr
Phe Asp Thr Ala
Phe Glu Ala Ser
Phe Glu Gly Thr
Phe Glu Ser Ala
Phe Glu Thr Gly
Phe Gly Glu Thr
Phe Gly Met Val
Phe Gly Thr Glu
Phe Gly Val Met
Phe Ile Ala Cys
Phe Ile Cys Ala
Phe Leu Ala Cys
Phe Leu Cys Ala
Phe Met Gly Val
Phe Met Val Gly
Phe Ser Ala Glu
Phe Ser Glu Ala
Phe Thr Ala Asp
Phe Thr Asp Ala
Phe Thr Glu Gly
Phe Thr Gly Glu
Phe Val Gly Met
Phe Val Met Gly
Gly Asp Val Tyr
Gly Asp Tyr Val
Gly Glu Phe Thr
Gly Glu Thr Phe
Gly Phe Glu Thr
Gly Phe Met Val
Gly Phe Thr Glu
Gly Phe Val Met
Gly Met Phe Val
Gly Met Val Phe
Gly Thr Glu Phe
Gly Thr Phe Glu
Gly Val Asp Tyr
Gly Val Phe Met
Gly Val Met Phe
Gly Val Tyr Asp
Gly Tyr Asp Val
Gly Tyr Val Asp
His Ala Glu Pro
His Ala Pro Glu
His Cys Pro Pro
His Glu Ala Pro
His Glu Pro Ala
His Pro Ala Glu
His Pro Cys Pro
His Pro Glu Ala
His Pro Pro Cys
Ile Ala Cys Phe
Ile Ala Phe Cys
Ile Cys Ala Phe
Ile Cys Phe Ala
Ile Phe Ala Cys
Ile Phe Cys Ala
Leu Ala Cys Phe
Leu Ala Phe Cys
Leu Cys Ala Phe
Leu Cys Phe Ala
Leu Phe Ala Cys
Leu Phe Cys Ala
Met Phe Gly Val
Met Phe Val Gly
Met Gly Phe Val
Met Gly Val Phe
Met Thr Thr Thr
Met Val Phe Gly
Met Val Gly Phe
Pro Ala Glu His
Pro Ala His Glu
Pro Cys His Pro
Pro Cys Pro His
Pro Glu Ala His
Pro Glu His Ala
Pro His Ala Glu
Pro His Cys Pro
Pro His Glu Ala
Pro His Pro Cys
Pro Pro Cys His
Pro Pro His Cys
Pro Ser Ser Tyr
Pro Ser Tyr Ser
Pro Tyr Ser Ser
Ser Ala Glu Phe
Ser Ala Phe Glu
Ser Glu Ala Phe
Ser Glu Phe Ala
Ser Phe Ala Glu
Ser Phe Glu Ala
Ser Pro Ser Tyr
Ser Pro Tyr Ser
Ser Ser Pro Tyr
Ser Ser Tyr Pro
Ser Tyr Pro Ser
Ser Tyr Ser Pro
Thr Ala Asp Phe
Thr Ala Phe Asp
Thr Asp Ala Phe
Thr Asp Phe Ala
Thr Glu Phe Gly
Thr Glu Gly Phe
Thr Phe Ala Asp
Thr Phe Asp Ala
Thr Phe Glu Gly
Thr Phe Gly Glu
Thr Gly Glu Phe
Thr Gly Phe Glu
Thr Met Thr Thr
2H-Indol-2-one, 4-[2-(dipropylamino)ethyl]-1,3-dihydro-7-hydroxy- glucuronide
Thr Thr Met Thr
Thr Thr Thr Met
Val Asp Gly Tyr
Val Asp Tyr Gly
Val Phe Gly Met
Val Phe Met Gly
Val Gly Asp Tyr
Val Gly Phe Met
Val Gly Met Phe
Val Gly Tyr Asp
Val Met Phe Gly
Val Met Gly Phe
Val Tyr Asp Gly
Val Tyr Gly Asp
Tyr Ala Ala Glu
Tyr Ala Glu Ala
Tyr Asp Gly Val
Tyr Asp Val Gly
Tyr Glu Ala Ala
Tyr Gly Asp Val
Tyr Gly Val Asp
Tyr Pro Ser Ser
Tyr Ser Pro Ser
Tyr Ser Ser Pro
Tyr Val Asp Gly
Tyr Val Gly Asp
6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-, (6b,11b,16b,17a)-Androsta-1,4-diene-17-c
8-Butanoylneosolaniol
8-Isobutanoylneosolaniol
3-Hydroxy-4-(3-hydroxy-1-propen-2-yl)-2-(3-methoxy-3-oxo-1-propen-2-yl)-5-methyl-5-vinylcyclohexyl 4-acetoxy-3-hydroxy-2-methylenebutanoate
6-amino-5-[(2-cyano-4-nitrophenyl)azo]-2-[[3-(4-hydroxybutoxy)propyl]amino]-4-methyl-3-Pyridinecarbonitrile
2-amino-5-[(2-cyano-4-nitrophenyl)azo]-6-[[3-(4-hydroxybutoxy) propyl]amino]-4-methyl-3-Pyridinecarbonitrile
TERT-BUTYL6-(5-(METHOXYCARBONYL)PYRIDIN-3-YL)-4-OXOSPIRO[CHROMAN-2,4-PIPERIDINE]-1-CARBOXYLATE
25,26,27,28-tetrahydroxycalix[4]arene monoethyl ether
Eprazinone 2HCl
D019141 - Respiratory System Agents > D005100 - Expectorants Eprazinone dihydrochloride is a gent with mucolytic, secretolytic, antitussive, and bronchial antispasmodic properties. Eprazinone dihydrochloride is a neurokinin 1 receptor (NK1R) ligand. Eprazinone dihydrochloride has the potential for chronic bronchitis treatment that improved pulmonary function and arterial partial pressure of oxygen[1][2].
(3R,4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-3-carboxylic acid
(2R,4R)-4-(((9H-FLUOREN-9-YL)METHOXY)CARBONYLAMINO)-1-(TERT-BUTOXYCARBONYL)PYRROLIDINE-2-CARBOXYLICACID
Pierreione B
A methoxyisoflavone that is isoflavone substituted by a methoxy group at position 3, a 2R,3-dihydroxy-3-methylbutoxyl group at position 4 and a dimethylpyran ring fused across positions 6 and 7. Isolated from Antheroporum pierrei, it exhibits antineoplastic activity.
Belumosudil
L - Antineoplastic and immunomodulating agents > L04 - Immunosuppressants > L04A - Immunosuppressants > L04AA - Selective immunosuppressants C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors
Boc-(2S,4S)-4-amino-1-Fmoc-pyrrolidine-2-carboxylic acid
1,1-Bis((R)-(dimethylamino)(phenyl)methyl)ferrocene
(6A,11B,16A,17A)-6,9-DIFLUORO-11-HYDROXY-16-METHYL-3-OXO-17-(1-OXOPROPOXY)ANDROSTA-1,4-DIENE-17-CARBOXYLIC ACID
3,3-[Oxybis(2,1-ethanediyloxy)]bis-1-propanamine (2Z)-2-butenedioate (1:2)
C10H24N2O3.2(C4H4O4) (452.2006)
Tetraethylene glycol 4-methylbenzyl ether tosylate
2-tert-butylcyclopenta-1,3-diene,carbanide,hafnium(4+)
1-{2-[(4-Chlorophenyl)amino]-2-oxoethyl}-N-(1-isopropylpiperidin-4-YL)-1H-indole-2-carboxamide
({3-[1-(4-Hydroxy-2-oxo-2H-chromen-3-YL)-propyl]-phenylcarbamoyl}-methyl)-carbamic acid tert-butyl ester
N-((1S)-1-(3-Chloro-1-naphthalenyl)ethyl)-2-(4-(4-fluorophenyl)-1-methyl-4-P iperidinyl)-N-methylacetamide
phosphono [(2E,7S,10E)-3,7,11,15-tetramethylhexadeca-2,10,14-trienyl] hydrogen phosphate
N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[[3-(1-pyrrolidinyl)-2-quinoxalinyl]thio]acetamide
3-[[(1-tert-butyl-5-tetrazolyl)methyl-(thiophen-2-ylmethyl)amino]methyl]-6-ethoxy-1H-quinolin-2-one
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
(6R,7R,8R)-8-(hydroxymethyl)-4-[oxo(2-pyrazinyl)methyl]-7-[4-(3-phenylprop-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
N-[(2S,3R,6R)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6R)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(2-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(4-methoxyphenyl)urea
N-[(2S,3R,6S)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3S,6S)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6R)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2S,3S,6S)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
N-[(2R,3R,6S)-6-[2-(2,3-dihydro-1H-inden-2-ylamino)-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-1,3-benzodioxole-5-carboxamide
1-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(3-pyridinyl)-1-triazolyl]ethyl]-3-oxanyl]-3-(2-methoxyphenyl)urea
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-[2-(2-methoxyphenyl)ethynyl]-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-phenylethanone
(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-azaniumyl-2-carboxylatoethyl]sulfanyl}-5-hydroxy-20-oxoicosa-7,9,11,14-tetraenoate
(1S,2S,4R,8R,9S,11R,12S,13S,19S)-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one
20-oxoleukotriene E4(1-)
A leukotriene anion that is the conjugate base of leukotriene E4 obtained by deprotonation of the two carboxy groups and protonation of the cysteinyl alpha-amino group; major species at pH 7.3.
(-)-(S)-B-973B
(-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1]. (-)-(S)-B-973B is a potent allosteric agonist and positive allosteric modulator of α7 nAChR, with antinociceptive activity[1].
9-[(3,3-dimethyloxiran-2-yl)(methoxy)methyl]-4,6-dihydroxy-12-methyl-3-(prop-1-en-2-yl)-3,4-dihydro-2h-1,10-dioxatetraphen-5-one
2-(3,4-dihydroxyphenyl)-6-(3,7-dimethylocta-2,6-dien-1-yl)-5,7-dihydroxy-3-methoxychromen-4-one
2-[5-(5,6-dimethoxy-1-benzofuran-2-yl)-2,5-dimethyloxolan-2-yl]-5,6-dimethoxy-1-benzofuran
4,8-bis(acetyloxy)-2-[2-(acetyloxy)ethylidene]-6,10-dimethyl-11-oxoundeca-5,9-dien-1-yl acetate
2-{2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-3,4-dihydroxyphenyl}-5,7-dihydroxy-3-methoxychromen-4-one
1,2,13,18,30,31-hexaazaoctacyclo[20.6.1.1²,⁹.1¹¹,¹⁵.1¹⁶,²⁰.0³,⁸.0¹⁴,¹⁷.0²³,²⁸]dotriaconta-3,5,7,9(32),12,18,22(29),23,25,27-decaene-12,19-diol
5,7-dihydroxy-8-methoxy-3-[(3-methylbut-2-en-1-yl)oxy]-2-{4-[(3-methylbut-2-en-1-yl)oxy]phenyl}chromen-4-one
(3s,8r)-3-(2,3-dihydroxy-4-methoxyphenyl)-5-hydroxy-8-methyl-8-(4-methylpent-3-en-1-yl)-2h,3h-pyrano[3,2-g]chromen-4-one
(3s)-3-(2,4-dihydroxy-5-methoxyphenyl)-5-hydroxy-8,8-dimethyl-10-(3-methylbut-2-en-1-yl)-2h,3h-pyrano[3,2-g]chromen-4-one
[(2r,3s,4s,5r,6r)-6-{[(3as,8ar,9ar)-8a-methyl-3-methylidene-2-oxo-3ah,4h,6h,7h,8h,9h,9ah-naphtho[2,3-b]furan-5-yl]methoxy}-3,4,5-trihydroxyoxan-2-yl]methyl acetate
5-hydroxy-3-(4-hydroxyphenyl)-8-(2-hydroxypropan-2-yl)-9-methoxy-6-(3-methylbut-2-en-1-yl)-8h,9h-furo[2,3-h]chromen-4-one
(2r,3r)-3,5-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-methyl-8-(4-methylpent-3-en-1-yl)-2h,3h-pyrano[3,2-g]chromen-4-one
3-(2,3-dihydroxy-4-methoxyphenyl)-5-hydroxy-8-methyl-8-(4-methylpent-3-en-1-yl)-2h,3h-pyrano[2,3-f]chromen-4-one
3-[3,4-dihydroxy-5-methoxy-2,6-bis(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxychromen-4-one
4,6-dihydroxy-9-(2-hydroxy-1-methoxy-3-methylbut-3-en-1-yl)-12-methyl-3-(prop-1-en-2-yl)-3,4-dihydro-2h-1,10-dioxatetraphen-5-one
(11r)-11-(3,4-dihydroxyphenyl)-4-(2-hydroxypropan-2-yl)-7-methoxy-8-(3-methylbut-2-en-1-yl)-3,10-dioxatricyclo[7.4.0.0²,⁶]trideca-1,4,6,8-tetraen-13-one
2-[3,4-dihydroxy-2-(3-methylbut-2-en-1-yl)phenyl]-5,7-dihydroxy-3-methoxy-8-(3-methylbut-2-en-1-yl)chromen-4-one
(2e,4r,6e,8r,10z)-8,12-bis(acetyloxy)-10-[(acetyloxy)methyl]-2,6-dimethyl-1-oxododeca-2,6,10-trien-4-yl acetate
(?)-(10r,10'r)-ligulacephalin b
{"Ingredient_id": "HBIN000194","Ingredient_name": "(?)-(10r,10'r)-ligulacephalin b","Alias": "NA","Ingredient_formula": "C26H28O7","Ingredient_Smile": "CC1(CCC(O1)(C)C2=CC3=CC(=C(C=C3O2)OC)OC)C4=CC5=CC(=C(C=C5O4)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "12802","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(?)-(10s,10's)-ligulacephalin b
{"Ingredient_id": "HBIN000199","Ingredient_name": "(?)-(10s,10's)-ligulacephalin b","Alias": "NA","Ingredient_formula": "C26H28O7","Ingredient_Smile": "CC1(CCC(O1)(C)C2=CC3=CC(=C(C=C3O2)OC)OC)C4=CC5=CC(=C(C=C5O4)OC)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "12803","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
5,7,3',4'-tetrahydroxy-3-methoxy-6-geranyl-flavone
{"Ingredient_id": "HBIN011179","Ingredient_name": "5,7,3',4'-tetrahydroxy-3-methoxy-6-geranyl-flavone","Alias": "NA","Ingredient_formula": "C26H28O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21112","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}